Condition: Incarcerated Individuals · Correctional Institutions · Sponsor: University of Wisconsin, Madison
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goal of this clinical trial is to improve health outcomes for incarcerated individuals by increasing medications for opioid use disorder (MOUD) use, using scalable and cost-effective methods that could be applied more broadly in the criminal justice system.
This description comes directly from the study's public registry record.
Jessica Vechinski, MSW · 414-899-4324 · jvechinski@wisc.edu
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria - Sites: * Have an interest in embedding or increasing the use of MOUD within their site * Have the funds to pay for medication for the duration of the study (24 months) * Agree to implement or continue the use of at least one medication for opioid use disorder * Have leadership support at all levels including from Secretary of DOC, medical director, wardens, etc. * Sign a memorandum of Understanding (MOU) or Information Sheet * Agree to provide data described in the Information Sheet Exclusion Criteria: * Failure to meet eligibility criteria
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| University of Wisconsin-Madison | Madison, Wisconsin, United States | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.